Largest health care companies by cash on hand
Cash and cash equivalents at the end of the latest fiscal year. Short-term investments are not counted.
Veradermics has the lowest figure of the 170 health care companies ranked by cash on hand, at CHF 18.4M, followed by CG Oncology (CHF 27.4M) and Heartflow (CHF 37.8M). Figures as of 19 Nov 2026, 19:24 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 170
- Lowest
- VeradermicsCHF 18.4M
- Median
- CHF 490M
- Combined market value
- CHF 7.54T
- Countries
- 14
Market values as of .
All countries▾
Health Care▾
All categories▾
| # | Company | Cash on hand ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | VeradermicsMANE · Health Care | CHF 18.4M | CHF 4.4B | CHF 103.64 | 1.66% down | 231% up | ||
| 2 | CG OncologyCGON · Health Care | CHF 27.4M | CHF 6.2B | CHF 68.88 | 2.01% up | 97% up | ||
| 3 | HeartflowHTFL · Health Care | CHF 37.8M | CHF 3.3B | CHF 38.01 | 1.87% down | 66% up | ||
| 4 | Oruka TherapeuticsORKA · Health Care | CHF 39.6M | CHF 5.6B | CHF 83.30 | 3.09% up | 255% up | ||
| 5 | Dianthus TherapeuticsDNTH · Health Care | CHF 43.1M | CHF 4.1B | CHF 72.52 | 2.32% up | 108% up | ||
| 6 | Rhythm PharmaceuticalsRYTM · Health Care | CHF 45.8M | CHF 6.8B | CHF 98.75 | 1.72% down | 18% up | ||
| 7 | Edgewise TherapeuticsEWTX · Health Care | CHF 51.6M | CHF 3.9B | CHF 35.20 | 0.81% up | 86% up | ||
| 8 | Mettler-Toledo InternationalMTD · Health Care | CHF 56.5M | CHF 28.6B | CHF 1,436.99 | 2.00% down | 24% up | ||
| 9 | Adaptive BiotechnologiesADPT · Health Care | CHF 59.5M | CHF 3.9B | CHF 24.15 | 0.53% up | 74% up | ||
| 10 | Encompass HealthEHC · Health Care | CHF 60.9M | CHF 11B | CHF 111.69 | 1.93% down | 20% up | ||
| 11 | ErascaERAS · Health Care | CHF 62.3M | CHF 4.2B | CHF 12.07 | 3.89% up | 395% up | ||
| 12 | ChemedCHE · Health Care | CHF 62.9M | CHF 6B | CHF 464.16 | 0.59% up | 27% up | ||
| 13 | TG TherapeuticsTGTX · Health Care | CHF 66.8M | CHF 8.3B | CHF 54.86 | 1.69% down | 117% up | ||
| 14 | Concentra Group Holdings ParentCON · Health Care | CHF 67.4M | CHF 4.4B | CHF 34.96 | 1.19% down | 116% up | ||
| 15 | Spyre TherapeuticsSYRE · Health Care | CHF 72.4M | CHF 7.9B | CHF 82.79 | 3.32% down | 332% up | ||
| 16 | ImmunityBioIBRX · Health Care | CHF 74.6M | CHF 5.9B | CHF 5.52 | 2.46% down | 232% up | ||
| 17 | BrightSpring Health ServicesBTSG · Health Care | CHF 74.6M | CHF 10.9B | CHF 54.58 | 5.37% down | 109% up | ||
| 18 | GlaukosGKOS · Health Care | CHF 76.6M | CHF 11.8B | CHF 198.71 | 1.01% up | 145% up | ||
| 19 | Travere TherapeuticsTVTX · Health Care | CHF 78.5M | CHF 3.9B | CHF 41.06 | 3.16% down | 45% up | ||
| 20 | Cooper CompaniesCOO · Health Care | CHF 93.3M | CHF 9.7B | CHF 50.76 | 1.00% down | 15% down | ||
| 21 | Corcept TherapeuticsCORT · Health Care | CHF 101.7M | CHF 6B | CHF 55.01 | 3.85% down | 10% down | ||
| 22 | CytokineticsCYTK · Health Care | CHF 103.4M | CHF 6.1B | CHF 43.49 | 0.40% up | 19% down | ||
| 23 | Protagonist TherapeuticsPTGX · Health Care | CHF 108.4M | CHF 6.9B | CHF 105.33 | 1.86% down | 51% up | ||
| 24 | Halozyme TherapeuticsHALO · Health Care | CHF 112.9M | CHF 8.8B | CHF 77.58 | 4.06% down | 39% up | ||
| 25 | Universal Health ServicesUHS · Health Care | CHF 116.3M | CHF 8.5B | CHF 147.89 | 5.83% down | 17% down | ||
| 26 | Henry ScheinHSIC · Health Care | CHF 131.7M | CHF 7.8B | CHF 70.76 | 2.16% down | 20% up | ||
| 27 | Dr. Reddy's LaboratoriesRDY · Health Care | CHF 138M | CHF 10.5B | CHF 12.58 | 0.53% down | 8% up | ||
| 28 | MSA SafetyMSA · Health Care | CHF 139.3M | CHF 5.8B | CHF 149.39 | 0.25% down | 16% up | ||
| 29 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | CHF 139.8M | CHF 6.2B | CHF 79.41 | 1.02% down | 129% up | ||
| 30 | VaxcytePCVX · Health Care | CHF 146.8M | CHF 7.9B | CHF 49.75 | 0.73% up | 23% up | ||
| 31 | Ligand PharmaceuticalsLGND · Health Care | CHF 147.6M | CHF 4.9B | CHF 244.17 | 3.15% down | 50% up | ||
| 32 | IDEXX LaboratoriesIDXX · Health Care | CHF 152M | CHF 45.9B | CHF 582.13 | 1.25% down | 1% up | ||
| 33 | Twist BioscienceTWST · Health Care | CHF 154.5M | CHF 6.5B | CHF 95.85 | 2.40% down | 346% up | ||
| 34 | PenumbraPEN · Health Care | CHF 157.7M | CHF 10.6B | CHF 269.92 | 0.25% down | 15% up | ||
| 35 | PACS GroupPACS · Health Care | CHF 166.3M | CHF 5.8B | CHF 36.65 | 6.22% down | 77% up | ||
| 36 | Madrigal PharmaceuticalsMDGL · Health Care | CHF 167.7M | CHF 7.8B | CHF 335.28 | 0.21% down | 27% down | ||
| 37 | Kodiak SciencesKOD · Health Care | CHF 177.1M | CHF 5.4B | CHF 82.62 | 0.08% up | 399% up | ||
| 38 | Charles River Laboratories InternationalCRL · Health Care | CHF 180.4M | CHF 13.3B | CHF 277.52 | 1.33% down | 106% up | ||
| 39 | Summit TherapeuticsSMMT · Health Care | CHF 190.1M | CHF 7.2B | CHF 9.01 | 1.62% up | 36% down | ||
| 40 | Arrowhead PharmaceuticalsARWR · Health Care | CHF 191.2M | CHF 5.2B | CHF 36.70 | 0.86% up | 13% up | ||
| 41 | Hims & Hers HealthHIMS · Health Care | CHF 193M | CHF 3.2B | CHF 13.63 | 5.28% down | 49% down | ||
| 42 | Option Care HealthOPCH · Health Care | CHF 196.3M | CHF 4B | CHF 26.69 | 0.28% down | 12% up | ||
| 43 | HaemoneticsHAE · Health Care | CHF 207.2M | CHF 4.6B | CHF 101.30 | 2.31% down | 64% up | ||
| 44 | LifeStance Health GroupLFST · Health Care | CHF 209.9M | CHF 4.2B | CHF 11.15 | 4.07% down | 123% up | ||
| 45 | GRAILGRAL · Health Care | CHF 210.8M | CHF 4B | CHF 89.03 | 3.31% up | 19% up | ||
| 46 | Definium TherapeuticsDFTX · Health Care | CHF 217.6M | CHF 3.4B | CHF 24.74 | 0.67% up | 168% up | ||
| 47 | Bio-TechneTECH · Health Care | CHF 223.4M | CHF 9.6B | CHF 61.37 | 0.05% down | 24% up | ||
| 48 | Amneal PharmaceuticalsAMRX · Health Care | CHF 238M | CHF 6.3B | CHF 17.98 | 2.65% down | 90% up | ||
| 49 | Mirum PharmaceuticalsMIRM · Health Care | CHF 250.4M | CHF 5.3B | CHF 80.98 | 3.73% up | 34% up | ||
| 50 | MiniMed GroupMMED · Health Care | CHF 251.5M | CHF 3.9B | CHF 13.79 | 3.83% down | 8% down | ||
| 51 | BrukerBRKR · Health Care | CHF 252.2M | CHF 8.1B | CHF 52.79 | 1.14% down | 44% up | ||
| 52 | Cogent BiosciencesCOGT · Health Care | CHF 263.3M | CHF 4.1B | CHF 23.54 | 0.29% up | 20% down | ||
| 53 | HealthEquityHQY · Health Care | CHF 269.2M | CHF 6.7B | CHF 81.24 | 1.09% down | 3% down | ||
| 54 | Axsome TherapeuticsAXSM · Health Care | CHF 272.6M | CHF 6B | CHF 113.75 | 0.58% up | 6% down | ||
| 55 | Scholar Rock HoldingSRRK · Health Care | CHF 273.1M | CHF 5.2B | CHF 42.26 | 4.30% up | 26% up | ||
| 56 | CRISPR TherapeuticsCRSP · Health Care | CHF 293.3M | CHF 3.2B | CHF 33.03 | 2.64% down | 18% down | ||
| 57 | Belite BioBLTE · Health Care | CHF 297.9M | CHF 5.2B | CHF 129.16 | 2.05% down | 43% up | ||
| 58 | Kymera TherapeuticsKYMR · Health Care | CHF 301.3M | CHF 8.7B | CHF 102.02 | 0.21% down | 87% up | ||
| 59 | Praxis Precision MedicinesPRAX · Health Care | CHF 301.6M | CHF 7.3B | CHF 260.85 | 1.27% up | 86% up | ||
| 60 | Lantheus HoldingsLNTH · Health Care | CHF 303.1M | CHF 5.6B | CHF 86.16 | 0.08% up | 90% up | ||
| 61 | AvantorAVTR · Health Care | CHF 308.4M | CHF 8.6B | CHF 12.75 | 1.72% down | 40% up | ||
| 62 | Ionis PharmaceuticalsIONS · Health Care | CHF 314.2M | CHF 3.8B | CHF 22.64 | 2.08% down | 63% down | ||
| 63 | Guardant HealthGH · Health Care | CHF 319.2M | CHF 16.9B | CHF 124.81 | 1.88% up | 45% up | ||
| 64 | TeleflexTFX · Health Care | CHF 319.5M | CHF 5.5B | CHF 138.69 | 0.92% down | 58% up | ||
| 65 | Bausch + LombBLCO · Health Care | CHF 323.3M | CHF 6.3B | CHF 17.50 | 1.03% down | 44% up | ||
| 66 | Revolution MedicinesRVMD · Health Care | CHF 323.9M | CHF 29.2B | CHF 134.91 | 0.01% up | 129% up | ||
| 67 | AlkermesALKS · Health Care | CHF 328M | CHF 6.5B | CHF 38.89 | 1.64% down | 66% up | ||
| 68 | Quest DiagnosticsDGX · Health Care | CHF 354.5M | CHF 24B | CHF 218.25 | 0.43% down | 38% up | ||
| 69 | STERISSTE · Health Care | CHF 371M | CHF 20.9B | CHF 215.00 | 1.86% down | 1% up | ||
| 70 | Merit Medical SystemsMMSI · Health Care | CHF 376.8M | CHF 4.3B | CHF 71.39 | 1.57% down | 1% up | ||
| 71 | 10x GenomicsTXG · Health Care | CHF 400M | CHF 6.4B | CHF 48.81 | 1.33% up | 247% up | ||
| 72 | ExelixisEXEL · Health Care | CHF 407.2M | CHF 13.6B | CHF 55.64 | 3.47% down | 63% up | ||
| 73 | BillionToOneBLLN · Health Care | CHF 418.6M | CHF 3.7B | CHF 76.92 | 0.45% down | 4% down | ||
| 74 | Krystal BiotechKRYS · Health Care | CHF 418.9M | CHF 7.9B | CHF 265.81 | 0.13% down | 54% up | ||
| 75 | Medpace HoldingsMEDP · Health Care | CHF 419.5M | CHF 15B | CHF 535.41 | 1.93% down | 10% up | ||
| 76 | Ensign GroupENSG · Health Care | CHF 425.3M | CHF 8.7B | CHF 149.74 | 3.04% down | 2% up | ||
| 77 | InsmedINSM · Health Care | CHF 430.8M | CHF 26.6B | CHF 121.44 | 20.10% up | 40% down | ||
| 78 | Globus MedicalGMED · Health Care | CHF 444.1M | CHF 7.7B | CHF 57.95 | 2.65% down | 14% down | ||
| 79 | Bio-Rad LaboratoriesBIO · Health Care | CHF 447.2M | CHF 8.4B | CHF 310.56 | 0.60% down | 22% up | ||
| 80 | Labcorp HoldingsLH · Health Care | CHF 449.3M | CHF 25.3B | CHF 311.49 | 0.47% down | 42% up | ||
| 81 | Elanco Animal HealthELAN · Health Care | CHF 460M | CHF 11.2B | CHF 22.43 | 0.45% down | 26% up | ||
| 82 | Smith & NephewSNN · Health Care | CHF 470.1M | CHF 10.5B | CHF 25.20 | 1.53% down | 5% down | ||
| 83 | RepligenRGEN · Health Care | CHF 477.7M | CHF 9.2B | CHF 143.86 | 1.29% down | 12% up | ||
| 84 | BridgeBio PharmaBBIO · Health Care | CHF 481.2M | CHF 12.9B | CHF 66.10 | 0.38% up | 21% up | ||
| 85 | ABIVAXABVX · Health Care | CHF 483.8M | CHF 6.1B | CHF 69.83 | 1.30% down | 32% down | ||
| 86 | WatersWAT · Health Care | CHF 496.1M | CHF 76.2B | CHF 387.84 | 1.41% down | 23% up | ||
| 87 | Zimmer Biomet HoldingsZBH · Health Care | CHF 499.6M | CHF 16.3B | CHF 86.08 | 1.29% down | 16% up | ||
| 88 | Royalty PharmaRPRX · Health Care | CHF 522.2M | CHF 33B | CHF 57.35 | 1.05% down | 79% up | ||
| 89 | LivaNovaLIVN · Health Care | CHF 536.4M | CHF 4.3B | CHF 78.11 | 2.10% down | 77% up | ||
| 90 | Becton, DickinsonBDX · Health Care | CHF 541M | CHF 48.8B | CHF 179.23 | 1.73% down | 45% up | ||
| 91 | ICONICLR · Health Care | CHF 546.3M | CHF 12.1B | CHF 161.68 | 1.84% down | 23% up | ||
| 92 | DaVitaDVA · Health Care | CHF 570.9M | CHF 8.3B | CHF 131.95 | 3.37% down | 40% up | ||
| 93 | Ascendis PharmaASND · Health Care | CHF 576.9M | CHF 14.2B | CHF 216.70 | 5.03% down | 29% up | ||
| 94 | Neurocrine BiosciencesNBIX · Health Care | CHF 601.8M | CHF 13.5B | CHF 132.92 | 3.30% down | 17% up | ||
| 95 | InsuletPODD · Health Care | CHF 604.4M | CHF 7.9B | CHF 114.15 | 3.39% down | 55% down | ||
| 96 | RadNetRDNT · Health Care | CHF 647.5M | CHF 4.6B | CHF 58.62 | 3.30% down | 9% down | ||
| 97 | West Pharmaceutical ServicesWST · Health Care | CHF 667.9M | CHF 23.2B | CHF 332.93 | 2.37% down | 57% up | ||
| 98 | Caris Life SciencesCAI · Health Care | CHF 672.1M | CHF 4.6B | CHF 15.88 | 3.49% down | 19% down | ||
| 99 | QiagenQGEN · Health Care | CHF 708.1M | CHF 8.6B | CHF 41.80 | 0.08% down | 9% up | ||
| 100 | SolventumSOLV · Health Care | CHF 741M | CHF 12.2B | CHF 72.03 | 1.32% down | 9% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Cash on hand is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 0.8440 CHF).
Questions and answers
Which health care companies have the lowest cash on hand?
Veradermics (CHF 18.4M), CG Oncology (CHF 27.4M) and Heartflow (CHF 37.8M) have the lowest cash on hand of the 170 health care companies ranked here as of 19 Nov 2026, 19:24 UTC.
How many health care companies are in this ranking?
170 are ranked by cash on hand.
What are these health care companies worth together?
The 170 health care companies ranked by cash on hand have a combined market value of CHF 7.54T as of 19 Nov 2026, 19:24 UTC.
What does ranking by cash on hand measure?
Cash and cash equivalents at the end of the latest fiscal year. Short-term investments are not counted.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest health care companies by cash on hand”, data as of 19 November 2026. https://funkfolio.com/companies/sector/health-care?by=cash-on-hand
Underlying data: Yahoo Finance; SEC EDGAR.